4.7 Article

Sugar Responses of Human Enterochromaffin Cells Depend on Gut Region, Sex, and Body Mass

期刊

NUTRIENTS
卷 11, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/nu11020234

关键词

serotonin; 5-hydroxytryptamine; 5-HT; glucose; enterochromaffin; obesity; duodenum; colon

资金

  1. Australian Research Council Linkage Grant [LP150100419]
  2. Australian Research Council [LP150100419] Funding Source: Australian Research Council

向作者/读者索取更多资源

Gut-derived serotonin (5-HT) is released from enterochromaffin (EC) cells in response to nutrient cues, and acts to slow gastric emptying and modulate gastric motility. Rodent studies also evidence a role for gut-derived 5-HT in the control of hepatic glucose production, lipolysis and thermogenesis, and in mediating diet-induced obesity. EC cell number and 5-HT content is increased in the small intestine of obese rodents and human, however, it is unknown whether EC cells respond directly to glucose in humans, and whether their capacity to release 5-HT is perturbed in obesity. We therefore investigated 5-HT release from human duodenal and colonic EC cells in response to glucose, sucrose, fructose and -glucoside (MG) in relation to body mass index (BMI). EC cells released 5-HT only in response to 100 and 300 mM glucose (duodenum) and 300 mM glucose (colon), independently of osmolarity. Duodenal, but not colonic, EC cells also released 5-HT in response to sucrose and MG, but did not respond to fructose. 5-HT content was similar in all EC cells in males, and colonic EC cells in females, but 3 to 4-fold higher in duodenal EC cells from overweight females (p < 0.05 compared to lean, obese). Glucose-evoked 5-HT release was 3-fold higher in the duodenum of overweight females (p < 0.05, compared to obese), but absent here in overweight males. Our data demonstrate that primary human EC cells respond directly to dietary glucose cues, with regional differences in selectivity for other sugars. Augmented glucose-evoked 5-HT release from duodenal EC is a feature of overweight females, and may be an early determinant of obesity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Gastroenterology & Hepatology

Jumping the chasm from postdoc to PI

Alyce M. Martin

Summary: The transition from postdoc to PI is a challenging process that is filled with a mix of emotions and obstacles. It is crucial to provide support and nurture those who successfully make this transition.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Distinguishing the contributions of neuronal and mucosal serotonin in the regulation of colonic motility

Alyce M. Martin, Lauren A. Jones, Lai Wei, Nick J. Spencer, Kenton M. Sanders, Seungil Ro, Damien J. Keating

Summary: This study demonstrates the important role of mucosal 5-HT release in distension-evoked colonic motility. When EC cells are absent, SERT inhibition no longer alters gut motility, indicating that ENS 5-HT does not regulate gut motility.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Rheumatology

Association Between Metabolically Different Adiposity Subtypes and Osteoarthritis: A Mendelian Randomization Study

Anwar Mulugeta, Tesfahun C. Eshetie, Gizat M. Kassie, Daniel Erku, Alemayehu Mekonnen, Amanda Lumsden, Elina Hypponen

Summary: This Mendelian randomization study investigates the causal effect of different metabolically defined adiposity subtypes on osteoarthritis. The results show that metabolically unfavorable and metabolically neutral adiposity are associated with increased odds of osteoarthritis, while the association with metabolically favorable adiposity is less clear. Furthermore, all three metabolically defined adiposity subtypes are associated with increased odds of knee osteoarthritis. Nonlinear analyses suggest a nonlinear relationship between metabolically unfavorable adiposity and osteoarthritis.

ARTHRITIS CARE & RESEARCH (2023)

Article Endocrinology & Metabolism

Metabolic profile-based subgroups can identify differences in brain volumes and brain iron deposition

Amanda L. Lumsden, Anwar Mulugeta, Ville-Petteri Makinen, Elina Hypponen

Summary: This study evaluated the associations between metabolic subgroups and biomarkers with brain MRI measures, and found differential associations between metabolism and biomarkers with brain neuroimaging characteristics. These findings may provide insights into the early risk factors associated with dementia.

DIABETES OBESITY & METABOLISM (2023)

Letter Gastroenterology & Hepatology

Single-cell gene expression links SARS-CoV-2 infection and gut serotonin

Alyce M. Martin, Michael Roach, Lauren A. Jones, Daniel Thorpe, Rosemary A. Coleman, Caitlin Allman, Robert Edwards, Damien J. Keating

Article Endocrinology & Metabolism

Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank

Muktar Ahmed, Ville-Petteri Makinen, Amanda Lumsden, Terry Boyle, Anwar Mulugeta, Sang Hong Lee, Ian Olver, Elina Hypponen

Summary: Metabolic profiles can predict the incidence of cancer, particularly the risk of obesity-related cancer, hematologic malignancies, and liver cancer. Elevated values from liver tests are strong predictors for later risk of liver cancer.

METABOLISM-CLINICAL AND EXPERIMENTAL (2023)

Article Nutrition & Dietetics

Milk consumption and risk of twelve cancers: A large-scale observational and Mendelian randomisation study

Amanda L. Lumsden, Anwar Mulugeta, Elina Hypponen

Summary: This study assessed the potential causal relationships between milk consumption and 12 types of cancer. The results showed a protective role of milk consumption in colorectal cancer, but a higher risk of breast cancer and premenopausal uterine cancer. Further investigation is needed to confirm these findings.

CLINICAL NUTRITION (2023)

Article Pharmacology & Pharmacy

Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank

Kitty Pham, Anwar Mulugeta, Amanda Lumsden, Elina Hypponen

Summary: This study explored the associations between LDL lowering and multiple disease outcomes or biomarkers using a Mendelian randomization phenome-wide association study (MR-PheWAS). The results showed genetic evidence supporting the positive and negative effects of LDL-C lowering through all four LDL-C-lowering pathways. Biomarker analyses indicated the effects of LDL-C lowering on lung function and hippocampal volume.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Medicine, General & Internal

Hypothesis-free discovery of novel cancer predictors using machine learning

Iqbal Madakkatel, Amanda L. Lumsden, Anwar Mulugeta, Ian Olver, Elina Hypponen

Summary: Cancer is a major cause of disease and death worldwide, and understanding the risk factors is crucial for prevention. This study used machine learning and statistical approaches to identify cancer risk factors from a large number of potential predictors. The findings suggest that besides smoking, older age and male sex, various personal characteristics, metabolic biomarkers, and physical measures are positively associated with cancer risk.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Microbiology

The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control

Jocelyn M. Choo, Alyce M. Martin, Steven L. Taylor, Emily Sun, Fredrick M. Mobegi, Tokuwa Kanno, Alyson Richard, Lucy D. Burr, Stevie Lingman, Megan Martin, Damien J. Keating, A. James Mason, Geraint B. Rogers

Summary: Long-term low-dose macrolide therapy has effects on the gut microbiome, leading to changes in immune and metabolic regulation. These changes are mediated by alterations in gut microbiome composition, affecting carbohydrate metabolism and short-chain fatty acid biosynthesis. Understanding these mechanisms can help identify the risks associated with long-term macrolide exposure and emphasize the importance of targeted therapy for maintaining gut microbiota.

MICROBIOLOGY SPECTRUM (2023)

Article Cell Biology

Alterations in GLP-1 and PYY release with aging and body mass in the human gut

Lauren A. Jones, Emily W. Sun, Amanda L. Lumsden, Daniel W. Thorpe, Rochelle A. Peterson, Dayan De Fontgalland, Luigi Sposato, Philippa Rabbitt, Paul Hollington, David A. Wattchow, Damien J. Keating

Summary: The lining of our intestinal surface contains hormone-producing cells that can sense and respond to the internal environment in our gut. In this study, it is found that GLP-1 and PYY release is greater in the distal regions of the human colon and is negatively correlated with body mass index in the small intestine. Additionally, aging is associated with decreased secretion of GLP-1 and PYY in the large intestine.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2023)

暂无数据